[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$bcab
$BCAB announces potential deals with Novartis/Pfizer, with a focus on the BioAtlas platform and positive FDA news driving investor interest. Market sentiment remains mixed as the company approaches year-end deal announcements.
About $bcab
$BCAB is a biotechnology company developing targeted therapies for cancer.
Engagements: XXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXXXX
X Week: XXXXX -XX%
X Month: XXXXXXX +108%
X Months: XXXXXXX +88%
X Year: XXXXXXX -XX%
1-Year High: XXXXXX on 2025-03-27
1-Year Low: X on 2025-05-11
Engagements by network (24h): X: XXX
Mentions: XX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX -XX%
X Month: XXX +254%
X Months: XXXXX +326%
X Year: XXXXX +141%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-01-27
Mentions by network (24h): X: XXX
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $bcab in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: XX
X Week: XX -XX%
X Month: XXX +140%
X Months: XXXXX +657%
X Year: XXXXX +335%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-01-27
The most influential creators that mention $bcab in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BioValues | X | XXXXX | XX | XXX |
| @Biobeats99 | X | XXX | X | XX |
Sentiment: XXX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XXX%
Daily Average: XX%
X Week: XXX% no change
X Month: XXX% +14%
X Months: XXX% no change
X Year: XXX% +13%
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-05-03
Most Supportive Themes:
- Positive FDA News and Nasdaq Compliance: (40%) The stock is gaining traction due to positive FDA news and approval of a Nasdaq compliance plan.
- BioAtlas Platform Potential: (25%) Mentions of the BioAtlas platform and its promise, with some noting the involvement of major pharmaceutical companies.
Most Critical Themes:
- Mixed Market Sentiment: (35%) Mixed market sentiment suggests caution despite positive developments, with some recommending the stock while others express negative sentiment.
Top $bcab Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"GIPR🚨💎 Keep this ticker on high watch. Known runner with high potential. $LXEH $CYH $LBGJ $IMG $COOT $SPRC $NITO $MIRA $AREB $BENF $AIRE $INEO $SLGB $BQ $RANI $CYCU $BYND $TNGX $RXT $CCTG $VCIG $LRE $NVFY $GTBP $SAFX $ENTX $INLF $GNPX $NDRA $BCAB $LUMN $OFAL $BATL $XXII"
X Link @GrindingToMax 2025-12-11T15:36Z XXX followers, XXX engagements
"$PGEN $BCAB $ENGS 📊 Unlock free expert-driven trading strategies and deep market insights. 🌍 Join a global community of investors and elevate your financial intelligence"
X Link @BurnsMcKinney01 2025-12-10T16:34Z XX followers, 1154 engagements
"$BCAB two more deals announced this morning (private bios with Novartis/Pfizer). Now in the final stretch for deals to be announced before Xmas week/EOY. So gives $BCAB X trading days to issue PR. If not $EXEL tomorrow then $INCY #1 pick for next week"
X Link @BioValues 2025-12-09T15:10Z 8895 followers, 2574 engagements
"$BCAB if it's $EXEL the deal should be announced early next week ahead of their Wed R/D day. If nothing then $INCY likely top contender at any second before Dec 19"
X Link @BioValues 2025-12-05T16:08Z 8891 followers, 1617 engagements